Crescent Biopharma, Inc. (CBIO) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -8.94M | -26.74M | -17.52M | -22.16M | -5.11M | -6.27M | 19.4M | -8.89M | -10.51M | -7.61M | -8.68M | -6.97M | -11.61M | -7.91M | -8.62M | -16.23M | -13.7M | -12.81M | -16.95M | -13.61M |
| Operating CF Margin % | -860.15% | -246.59% | - | - | - | - | - | - | - | -76149.97% | - | - | - | - | - | -21640.88% | - | -72661.36% | -19577.48% | -9585512.68% |
| Operating CF Growth % | -75.03% | -326.54% | -190.32% | -149.19% | 51.41% | 17.68% | 323.45% | -27.51% | 9.46% | 3.75% | -0.77% | 57.03% | 15.27% | 38.22% | 49.15% | -19.24% | 3.02% | -32.22% | -47.31% | 6.46% |
| Net Income | -23.28M | 22.77M | -24.61M | -21.79M | -2.34M | -37.88M | -2.63M | -10.1M | -10.74M | -9.08M | -9.2M | -8.26M | -10.36M | -10.24M | -8.52M | -13.27M | -14.65M | -17.42M | -17.33M | -14.4M |
| Depreciation & Amortization | 64K | 649K | 0 | 2K | 0 | 35.14M | 0 | 12.42K | 14.62K | 23.3K | 269.94K | 265.87K | 43.84K | 45.72K | 47.35K | 54.77K | 59.31K | 61.64K | 256.82K | 67.48K |
| Stock-Based Compensation | 4.11M | 7.31M | 0 | 0 | 405.43K | 1.16M | 0 | 1.25M | 1.23M | 0 | 0 | 0 | 870.18K | 899.2K | 913.98K | 963.76K | 1.08M | 1.32M | 0 | 1.56M |
| Deferred Taxes | 0 | -831K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 10.17M | -37.41M | 2.11M | -4.43M | 0 | -7.08M | 19.06M | 174.05K | 169.57K | 1.14M | 887.84K | 858.09K | 219.12K | 213.85K | 208.68K | 207.16K | 198.81K | 194.08K | 1.59M | 184.94K |
| Working Capital Changes | 0 | -19.24M | 4.97M | 4.06M | -3.17M | 2.39M | 2.98M | -231.14K | -1.18M | 299.87K | -638.45K | 160.1K | -2.38M | 1.17M | -1.26M | -4.19M | -383.87K | 3.04M | -1.46M | -1.03M |
| Change in Receivables | 18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -2.31M | 1.02M | 1.49M | -206.37K | -224.63K | -252.49K | 1.48M | 195.23K | -112.58K | 538.23K | 88.4K | -238.66K | -490.04K | 118.07K | -418.82K | -1.01M | 168.56K | 717.18K | 215.84K | -966.21K |
| Cash from Investing | -8.15M | -72.19M | -586K | -140K | 0 | 30K | 9.97K | -2.53K | -7.44K | -801 | -7.87K | -10.53K | -2.2K | 0 | -2.48K | -41.19K | -40.52K | -2.45K | -4.33K | -5.1K |
| Capital Expenditures | -147K | -82K | -586K | -140K | 0 | 0 | 9.97K | -2.53K | -7.44K | -801 | -7.87K | -10.53K | -2.2K | 0 | -2.48K | -41.19K | -40.52K | -2.45K | -4.33K | -5.1K |
| CapEx % of Revenue | 14.15% | 0.76% | - | - | - | - | - | - | - | 8.01% | - | - | - | - | - | 54.91% | - | 13.88% | 5.01% | 3592.96% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -8M | -74.33M | 0 | 0 | 0 | 30K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -6.95M | 178.86M | -1.27M | 145.39M | 0 | 41.03M | -5.4K | 500 | 4.9K | 999 | 61.62K | 20.11K | 28.74M | 4.16M | 0 | 0 | 0 | 1.14M | 20.79K | 0 |
| Debt Issued (Net) | 0 | 0 | -14K | 14K | 0 | 37.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 179.04M | -1.43M | -172K | 0 | 4.32M | -5.4K | 500 | 4.9K | 999 | 61.62K | 20.11K | 28.71M | 4.16M | 0 | 0 | 0 | 1.14M | 20.79K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -177K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -6.95M | -177K | 177K | 145.55M | 0 | -760K | 0 | 0 | 0 | 0 | 0 | 0 | 33.77K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -24.03M | 79.93M | -19.38M | 147.03M | -5.11M | 34.77M | -22.39M | -8.9M | -10.51M | -7.61M | -8.63M | -6.97M | 17.13M | -3.75M | -8.62M | -16.27M | -13.74M | -11.67M | -16.93M | -13.62M |
| Free Cash Flow | -9.08M | 22.13M | -18.11M | -22.3M | -5.11M | -3.7M | 19.41M | -8.9M | -10.52M | -7.62M | -8.69M | -6.99M | -11.61M | -7.91M | -8.62M | -16.27M | -13.74M | -12.81M | -16.95M | -13.62M |
| FCF Margin % | -874.3% | 204.1% | - | - | - | - | - | - | - | -76158% | - | - | - | - | - | -21695.8% | - | -72675.25% | -19582.49% | -9589105.63% |
| FCF Growth % | -77.91% | 697.95% | -193.3% | -150.69% | 51.45% | 51.4% | 323.36% | -27.35% | 9.41% | 3.74% | -0.83% | 57.07% | 15.5% | 38.23% | 49.15% | -19.5% | 2.76% | -31.72% | -47.14% | 6.47% |
| FCF per Share | -0.30 | 1.10 | -1.09 | -5.78 | -0.26 | -0.19 | 0.30 | -0.14 | -0.16 | -0.12 | -0.14 | -0.11 | -0.19 | -0.15 | -0.16 | -0.31 | -0.26 | -0.25 | -0.33 | -0.26 |
| FCF Conversion (FCF/Net Income) | 0.38x | 0.29x | 0.71x | 1.02x | 0.34x | 0.35x | -1.97x | 0.88x | 0.98x | 0.84x | 0.94x | 0.84x | 1.12x | 0.77x | 1.01x | 1.22x | 0.93x | 0.74x | 0.98x | 0.95x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |